您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    2019年我国伴随诊断产业发展状况及趋势分析

    摘要

    伴随诊断产业在医疗体系中的作用越来越重要。在各种有利政策的加持下,中国的伴随诊断产业步入了成长期,PCR、FISH、IHC、NGS等技术日臻成熟,液体活检、PDC、PDX、类器官等领域先进的技术平台也被逐渐开发出来,形成技术平台多样化、产品多样化的格局,实现了各种技术和产品互为补充。一批从事伴随诊断事业的企业迅速发展并壮大,成为某一细分领域的龙头,在产品端不断创新,市场规模逐年扩大。但目前中国伴随诊断产业市场集中度、成果转化率不高,还处于跟跑阶段,要实现领跑,还需要加大产业创新的力度,从临床需求出发设计产品,形成“良币驱逐劣币”的生态。

    <<
    >>

    Abstract

    The role of the diagnostic industry in the medical system is becoming more and more important. With the support of various favorable policies,China’s adjoint diagnostic industry has entered a growing period,with PCR,FISH,IHC,NGS and other technologies maturing,and advanced technical platforms such as liquid biopsy,PDC,PDX and organ-like have been developed gradually to form a diversified pattern of technological platforms and products,complementing each other with various technologies and products. A number of enterprises engaged in the diagnostic industry have developed rapidly and become the leader of a segment of the field,innovation in the product side,the market scale is expanding year by year. But at present,China’s accompanying diagnostic industry market concentration degree is not enough,the result conversion rate is not high,is still in the follow-up stage,in order to realize the leading run,but also needs to strengthen the industrial innovation,from the clinical needs of design products,to form “good money evictions bad money” ecology.

    <<
    >>
    作者简介
    任涛:任涛,博士,合肥中科普瑞昇生物医药科技有限公司总经理,中科院合肥技术创新院精准靶向药物工程中心副主任,入选安徽省“百人计划”。
    陈程:陈程,博士,合肥中科普瑞昇生物医药科技有限公司医学技术部总监。
    黄涛:黄涛,合肥中科普瑞昇生物医药科技有限公司医学技术中心主任。
    <<
    >>
    相关报告